About Revvity
Revvity is a publicly listed company founded in 2023. Revvity is engaged in advancing human health through scientific solutions. It operates on a Professional Services, Licensing Model, and HealthTech model. The company has 11,000 employees. Revvity has completed 1 acquisition, including Advanced Chemistry Development Labs. Its website revvity.com draws about 229 thousand monthly visits. Revvity offers products and services including Antibodies & Tools, Assays & Platforms, and Screening Tools. Its focus areas include Biotechnology, Life Sciences, Diagnostics and Specialty Diagnostics. Its legal entity is Revvity, Inc.
Company details
Revvity is involved in providing comprehensive life science solutions, technologies, and services that span from discovery to cure. The company is focused on revolutionizing biomedical research through translational multi-omics, biomarker identification, imaging, prediction, screening, detection, diagnosis, and informatics. Solutions are offered to academia, pharma, biotech, clinical laboratories, healthcare professionals, and CROs. Innovative tools and services are provided for reproductive health, immunodiagnostics, and preclinical drug discovery across various sectors.
- Employees 11,000
- Stage Public
- SectorsHealthcare
- Website category Computers Electronics and Technology · Graphics Multimedia and Web Design
- Website revvity.com
- Social LinkedIn X Facebook
- Legal Name Revvity, Inc.
- Annual Revenue$2.86 B (USD)3.67as on Dec 31, 2025
- Net Profit$242.02 M (USD)-18.19as on Dec 31, 2025
- EBITDA$833.15 M (USD)-0.62as on Dec 31, 2025
- Employee Count11,000
- Investments & Acquisitions
Products & Services of Revvity
Revvity offers a comprehensive portfolio of products and services, including Antibodies & Tools, Assays & Platforms, and Screening Tools.
Tools for target and hit discovery are provided.
Solutions for lead and process development are offered.
Tools for early detection screening are made available.
People of Revvity
548 people are tracked at Revvity (144 in leadership, 9 in board & advisors, 395 in team); the tracked headcount is 11,000.
| Name | Role | Group |
|---|---|---|
Olivia Bushey | Director, Corporate Financial Planning & Analysis | Leadership |
Karim Asaad | Managing Director Emerging Markets And South East Asia | Leadership |
Mike Kozowyk | Sales Director | Leadership |
Mauro Segreto | Director Of Cloudops | Leadership |
Pete Tortorelli | Gm/ Managing Director At Omni/ Revvity | Leadership |
Marek Dobrowolski | Head Of Nexcelom Software | Leadership |
Ian Lane | Director Of Software Development, Ecommerce | Leadership |
Volker Eckelt | Strategic Market Analysis Director | Leadership |
Dennis Pump | Director R&d Software | Leadership |
Bhawana Agrawal | Sr Director - Global Integration And Inventory Management | Leadership |
Christopher Boynton | Vice President, Marketing & Ecommerce | Leadership |
Rick Percuoco | Vice President Of Cloud Operations | Leadership |
Ruth Brignall | Director Of Scientific Affairs | Leadership |
Norm Lord | Vice President, Digital Products | Leadership |
Chris Lloyd | Director Cell Based Screening | Leadership |
Patrycja Dzierzawa | Finance Business Partner Europe - Reproductive Health Business | Leadership |
Miikka Tahtinen | Director - Global IT Infrastructure & Operations | Leadership |
David Bolton | Director Commercial Operations, EU & NA | Leadership |
Bradley H. Smith | Senior Manager, Creative + Content Strategy & Operations, Head Of Creative Services | Leadership |
Alex Lawrence | Director Strategy Corporate Development | Leadership |
528 more people are available in the full profile.
Complete people profiles for Revvity
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Revvity
Revvity is a publicly listed company on the NYSE with ticker symbol RVTY in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date03 Aug 1984
- Listed onNYSE: RVTY
- Listed entityRevvity, Inc.
- Exchange sectorHealth technology
- ISINUS7140461093
- Share price$155.08 (-0.34% on the day) · 2026-10-13
- Market capitalisation$17.30B
- Price to earnings73.7
- EPS (diluted, trailing year)$2.11
- Dividend yield0.18%
- Volume (last session)1,387,588
Financials of Revvity
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $2.86B | $242.0M | $833.1M |
| 2024 | $2.76B | $295.8M | $838.4M |
| 2023 | $2.75B | -$118.4M | $831.3M |
| 2022 | $3.31B | $569.2M | $1.21B |
| 2021 | $3.83B | $943.2M | $1.65B |
Detailed financial statements for Revvity
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Revvity
Revvity has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Advanced Chemistry Development Labs.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Cheminformatics solutions for R&D in chemistry are developed and provided. | acdlabs.com | Toronto, Canada | 1994 | Nov 2025 | •••• |
Complete acquisition details for Revvity
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Revvity
3 dated milestones of Revvity across 41 years, from founding to its latest funding, stage changes and deals.
- IPO Lists on the stock exchange (IPO).
- Founded Revvity is founded.
- Acquisition Acquires Advanced Chemistry Development Labs.
Web traffic of Revvity
The website of Revvity (revvity.com) receives about 229.2K visits a month and ranks #195,469 among all websites worldwide, #1,919 in Graphics Multimedia and Web Design.
- Monthly visits229.2K
▲ 3.8% vs previous month
- Unique visitors99.4K
per month
- Global rank#195,469
among all websites
- Category rank#1,919
Computers Electronics and Technology · Graphics Multimedia and Web Design
- Bounce rate46%
- Pages per visit2.5
- Average visit2 min 15 sec
- DevicesDesktop 54% · Mobile 46%
Websites whose visitors overlap most with Revvity. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| linkedin.com | 100% | 1.9B | #18 | View details | |
| instagram.com | 100% | 7.1B | #4 | View details | |
| github.com | 100% | 542.6M | #65 | View details | |
| reddit.com | 98% | 4.4B | #9 | View details | |
| facebook.com | 98% | 12.1B | #3 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 13 similar websites and full traffic analytics for Revvity
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Revvity
Complete news archive for Revvity
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Revvity
Revvity was founded in 2023.
Revvity has 11,000 employees.
Annual revenue of Revvity is $2.86B as on Dec 31, 2025.
Revvity is involved in providing comprehensive life science solutions, technologies, and services that span from discovery to cure. The company is focused on revolutionizing biomedical research through translational multi-omics, biomarker identification, imaging, prediction, screening, detection, diagnosis, and informatics. Solutions are offered to academia, pharma, biotech, clinical laboratories, healthcare professionals, and CROs. Innovative tools and services are provided for reproductive health, immunodiagnostics, and preclinical drug discovery across various sectors.
Revvity offers Antibodies & Tools, Assays & Platforms, and Screening Tools.
Yes, Revvity is publicly traded on NYSE under the ticker symbol RVTY.
Revvity has made 1 acquisition, including Advanced Chemistry Development Labs.
Revvity operates through Revvity, Inc..
The website of Revvity receives about 229 thousand visits a month and ranks #195,469 among all websites worldwide.